In this scenario, ROS primarily function as an inhibitor of tumorigenesis, and missense SDH gene variants therefore act, somewhat counter-intuitively, as anti-oncogenic tumor suppressors in sympathetic tissues. Here, SDHB is linked to neoplasm.